BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

303 related articles for article (PubMed ID: 16733218)

  • 21. Demonstration of EGFR gene copy loss in colorectal carcinomas by fluorescence in situ hybridization (FISH): a surrogate marker for sensitivity to specific anti-EGFR therapy?
    Sauer T; Guren MG; Noren T; Dueland S
    Histopathology; 2005 Dec; 47(6):560-4. PubMed ID: 16324192
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Detection of c-kit-activating mutations in gastrointestinal stromal tumors by high-resolution amplicon melting analysis.
    Willmore C; Holden JA; Zhou L; Tripp S; Wittwer CT; Layfield LJ
    Am J Clin Pathol; 2004 Aug; 122(2):206-16. PubMed ID: 15323137
    [TBL] [Abstract][Full Text] [Related]  

  • 23. p53 null mutations undetected by immunohistochemical staining predict a poor outcome with early-stage non-small cell lung carcinomas.
    Hashimoto T; Tokuchi Y; Hayashi M; Kobayashi Y; Nishida K; Hayashi S; Ishikawa Y; Tsuchiya S; Nakagawa K; Hayashi J; Tsuchiya E
    Cancer Res; 1999 Nov; 59(21):5572-7. PubMed ID: 10554037
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Aneusomy of chromosomes 7, 8, and 17 and amplification of HER-2/neu and epidermal growth factor receptor in Gleason score 7 prostate carcinoma: a differential fluorescent in situ hybridization study of Gleason pattern 3 and 4 using tissue microarray.
    Skacel M; Ormsby AH; Pettay JD; Tsiftsakis EK; Liou LS; Klein EA; Levin HS; Zippe CD; Tubbs RR
    Hum Pathol; 2001 Dec; 32(12):1392-7. PubMed ID: 11774175
    [TBL] [Abstract][Full Text] [Related]  

  • 25. EGFR tyrosine kinase domain mutations are detected in histologically normal respiratory epithelium in lung cancer patients.
    Tang X; Shigematsu H; Bekele BN; Roth JA; Minna JD; Hong WK; Gazdar AF; Wistuba II
    Cancer Res; 2005 Sep; 65(17):7568-72. PubMed ID: 16140919
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Polysomy of chromosome 17 in breast cancer tumors showing an overexpression of ERBB2: a study of 175 cases using fluorescence in situ hybridization and immunohistochemistry.
    Salido M; Tusquets I; Corominas JM; Suarez M; Espinet B; Corzo C; Bellet M; Fabregat X; Serrano S; Solé F
    Breast Cancer Res; 2005; 7(2):R267-73. PubMed ID: 15743507
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Color multiplex polymerase chain reaction for quantitative analysis of epidermal growth factor receptor genes in colorectal adenocarcinoma.
    Layfield LJ; Bernard PS; Goldstein NS
    J Surg Oncol; 2003 Aug; 83(4):227-31. PubMed ID: 12884235
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The incidence of topoisomerase II-alpha genomic alterations in adenocarcinoma of the breast and their relationship to human epidermal growth factor receptor-2 gene amplification: a fluorescence in situ hybridization study.
    Hicks DG; Yoder BJ; Pettay J; Swain E; Tarr S; Hartke M; Skacel M; Crowe JP; Budd GT; Tubbs RR
    Hum Pathol; 2005 Apr; 36(4):348-56. PubMed ID: 15891995
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Epidermal growth factor receptor--its expression and copy numbers of EGFR gene in patients with head and neck squamous cell carcinomas.
    Mrhalova M; Plzak J; Betka J; Kodet R
    Neoplasma; 2005; 52(4):338-43. PubMed ID: 16059652
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Investigation of HER2 overexpression in non-small cell lung cancer.
    Ugocsai K; Mándoky L; Tiszlavicz L; Molnár J
    Anticancer Res; 2005; 25(4):3061-6. PubMed ID: 16080566
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Epidermal growth factor receptor in non-small-cell lung carcinomas: correlation between gene copy number and protein expression and impact on prognosis.
    Hirsch FR; Varella-Garcia M; Bunn PA; Di Maria MV; Veve R; Bremmes RM; Barón AE; Zeng C; Franklin WA
    J Clin Oncol; 2003 Oct; 21(20):3798-807. PubMed ID: 12953099
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Epidermal growth factor receptor gene amplification and expression in disseminated pediatric low-grade gliomas.
    Tabori U; Rienstein S; Dromi Y; Leider-Trejo L; Constantini S; Burstein Y; Dvir R; Amariglio N; Toren A; Rechavi G; Izraeli S; Aviram A
    J Neurosurg; 2005 Oct; 103(4 Suppl):357-61. PubMed ID: 16270688
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Type I receptor tyrosine kinases are associated with hormone escape in prostate cancer.
    Bartlett JM; Brawley D; Grigor K; Munro AF; Dunne B; Edwards J
    J Pathol; 2005 Mar; 205(4):522-9. PubMed ID: 15685688
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Protein expression and gene amplification of epidermal growth factor receptor in thymomas.
    Ionescu DN; Sasatomi E; Cieply K; Nola M; Dacic S
    Cancer; 2005 Feb; 103(3):630-6. PubMed ID: 15630697
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Frequent overexpression of epidermal growth factor receptor (EGFR) in mammary high grade ductal carcinomas with myoepithelial differentiation.
    Shien T; Tashiro T; Omatsu M; Masuda T; Furuta K; Sato N; Akashi-Tanaka S; Uehara M; Iwamoto E; Kinoshita T; Fukutomi T; Tsuda H; Hasegawa T
    J Clin Pathol; 2005 Dec; 58(12):1299-304. PubMed ID: 16311351
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Selection pressures of TP53 mutation and microenvironmental location influence epidermal growth factor receptor gene amplification in human glioblastomas.
    Okada Y; Hurwitz EE; Esposito JM; Brower MA; Nutt CL; Louis DN
    Cancer Res; 2003 Jan; 63(2):413-6. PubMed ID: 12543796
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Role of epidermal growth factor receptor overexpression, K-ras point mutation and c-myc amplification in the carcinogenesis of non-small cell lung cancer.
    Sekine I; Takami S; Guang SG; Yokose T; Kodama T; Nishiwaki Y; Kinoshita M; Matsumoto H; Ogura T; Nagai K
    Oncol Rep; 1998; 5(2):351-4. PubMed ID: 9468555
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Expression of mutated epidermal growth factor receptor by non-small cell lung carcinomas.
    Garcia de Palazzo IE; Adams GP; Sundareshan P; Wong AJ; Testa JR; Bigner DD; Weiner LM
    Cancer Res; 1993 Jul; 53(14):3217-20. PubMed ID: 8391918
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Co-overexpression of fibroblast growth factor 3 and epidermal growth factor receptor is correlated with the development of nonsmall cell lung carcinoma.
    Tai AL; Sham JS; Xie D; Fang Y; Wu YL; Hu L; Deng W; Tsao GS; Qiao GB; Cheung AL; Guan XY
    Cancer; 2006 Jan; 106(1):146-55. PubMed ID: 16329133
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Global search for chromosomal abnormalities in infiltrating ductal carcinoma of the breast using array-comparative genomic hybridization.
    Somiari SB; Shriver CD; He J; Parikh K; Jordan R; Hooke J; Hu H; Deyarmin B; Lubert S; Malicki L; Heckman C; Somiari RI
    Cancer Genet Cytogenet; 2004 Dec; 155(2):108-18. PubMed ID: 15571796
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.